Kodiak Sciences Inc.
We are a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases
$13.00 - $15.00
Morgan Stanley, BofA Merrill Lynch, Barclays, Chardan
To view the prospectus for Kodiak Sciences Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253